{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:33:10Z","timestamp":1773779590025,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Program of Youth Science and Technology Innovation and Entrepreneurship Outstanding Talents (Team) of Jilin Province, China","award":["No. 20230508063RC"],"award-info":[{"award-number":["No. 20230508063RC"]}]},{"name":"The Excellent Youth Training Foundation of Jilin University, China","award":["No. 419080520665"],"award-info":[{"award-number":["No. 419080520665"]}]},{"name":"The Innovation and Entrepreneurship Talent Funding Program of Jilin Province, China."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01588-2","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T21:13:46Z","timestamp":1739826826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Application of CT-based radiomics combined with laboratory tests such as AFP and PIVKA-II in preoperative prediction of pathologic grade of hepatocellular carcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Meng","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siwen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"3","key":"1588_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-a Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Ca-a Cancer J Clin"},{"issue":"5","key":"1588_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1159\/000517992","volume":"10","author":"H Shinkawa","year":"2021","unstructured":"Shinkawa H, Tanaka S, Kabata D, Takemura S, Amano R, Kimura K, Kinoshita M, Kubo S. The prognostic impact of Tumor differentiation on recurrence and survival after resection of Hepatocellular Carcinoma is dependent on Tumor size. Liver Cancer. 2021;10(5):461\u201372.","journal-title":"Liver Cancer"},{"issue":"7","key":"1588_CR3","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.prp.2017.03.002","volume":"213","author":"L Zhou","year":"2017","unstructured":"Zhou L, Rui JA, Zhou WX, Wang SB, Chen SG, Qu Q. Edmondson-Steiner grade: a crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio. Pathol Res Pract. 2017;213(7):824\u201330.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"1588_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.amjsurg.2021.03.065","volume":"223","author":"SH Lin","year":"2022","unstructured":"Lin SH, Eng HL, Liu YW, Lin CC, Yong CC, Wang CC, Chen CL, Kuo FY, Cheng YF, Wang JH, et al. Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection. Am J Surg. 2022;223(2):339\u201345.","journal-title":"Am J Surg"},{"issue":"3","key":"1588_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2214\/AJR.18.20268","volume":"212","author":"F Vernuccio","year":"2019","unstructured":"Vernuccio F, Rosenberg MD, Meyer M, Choudhury KR, Nelson RC, Marin D. Negative biopsy of focal hepatic lesions: decision Tree Model for Patient Management. AJR Am J Roentgenol. 2019;212(3):677\u201385.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"1588_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s00261-019-02299-3","volume":"45","author":"JM Miranda Magalhaes Santos","year":"2020","unstructured":"Miranda Magalhaes Santos JM, Clemente Oliveira B, Araujo-Filho JAB, Assuncao-Jr AN, de Carlos Tavares Rocha MMFA, Horvat C, Menezes JV, Horvat MR. State-of-the-art in radiomics of hepatocellular carcinoma: a review of basic principles, applications, and limitations. Abdom Radiol (NY). 2020;45(2):342\u201353.","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"1588_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563\u201377.","journal-title":"Radiology"},{"issue":"1","key":"1588_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12880-019-0321-9","volume":"19","author":"J Wu","year":"2019","unstructured":"Wu J, Liu A, Cui J, Chen A, Song Q, Xie L. Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images. BMC Med Imaging. 2019;19(1):23.","journal-title":"BMC Med Imaging"},{"key":"1588_CR9","doi-asserted-by":"crossref","unstructured":"Hu X, Li C, Wang Q, Wu X, Chen Z, Xia F, Cai P, Zhang L, Fan Y, Ma K. Development and External Validation of a Radiomics Model Derived from Preoperative Gadoxetic Acid-enhanced MRI for Predicting histopathologic Grade of Hepatocellular Carcinoma. Diagnostics (Basel) 2023, 13(3).","DOI":"10.3390\/diagnostics13030413"},{"issue":"1","key":"1588_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40644-019-0197-5","volume":"19","author":"QY Shan","year":"2019","unstructured":"Shan QY, Hu HT, Feng ST, Peng ZP, Chen SL, Zhou Q, Li X, Xie XY, Lu MD, Wang W, et al. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation. Cancer Imaging. 2019;19(1):11.","journal-title":"Cancer Imaging"},{"key":"1588_CR11","doi-asserted-by":"publisher","first-page":"102718","DOI":"10.1016\/j.eclinm.2024.102718","volume":"74","author":"L Guo","year":"2024","unstructured":"Guo L, Hao X, Chen L, Qian Y, Wang C, Liu X, Fan X, Jiang G, Zheng D, Gao P, et al. Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort study. EClinicalMedicine. 2024;74:102718.","journal-title":"EClinicalMedicine"},{"key":"1588_CR12","doi-asserted-by":"publisher","first-page":"1295575","DOI":"10.3389\/fonc.2024.1295575","volume":"14","author":"Y Huang","year":"2024","unstructured":"Huang Y, Chen L, Ding Q, Zhang H, Zhong Y, Zhang X, Weng S. CT-based radiomics for predicting pathological grade in hepatocellular carcinoma. Front Oncol. 2024;14:1295575.","journal-title":"Front Oncol"},{"issue":"3","key":"1588_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jncc.2023.02.001","volume":"3","author":"J Yang","year":"2023","unstructured":"Yang J, Yang Z, Zeng X, Yu S, Gao L, Jiang Y, Sun F. Benefits and harms of screening for hepatocellular carcinoma in high-risk populations: systematic review and meta-analysis. J Natl Cancer Cent. 2023;3(3):175\u201385.","journal-title":"J Natl Cancer Cent"},{"issue":"3","key":"1588_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.32604\/biocell.2024.048244","volume":"48","author":"Y Ma","year":"2024","unstructured":"Ma Y, Wang S, Ding H. Bioinformatics analysis and experimental validation of cystathionine-gamma-lyase as a potential prognosis biomarker in hepatocellular carcinoma. Biocell. 2024;48(3):463\u201371.","journal-title":"Biocell"},{"issue":"7","key":"1588_CR15","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.32604\/biocell.2023.027026","volume":"47","author":"B Peng","year":"2023","unstructured":"Peng B, Ge Y, Yin G. A novel prognostic gene signature, nomogram and immune landscape based on tanshinone IIA drug targets for hepatocellular carcinoma: Comprehensive bioinformatics analysis and in vitro experiments. Biocell. 2023;47(7):1519\u201335.","journal-title":"Biocell"},{"issue":"3","key":"1588_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3748\/wjg.v19.i3.339","volume":"19","author":"JY Choi","year":"2013","unstructured":"Choi JY, Jung SW, Kim HY, Kim M, Kim Y, Kim DG, Oh EJ. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP. World J Gastroenterol. 2013;19(3):339\u201346.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1588_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12885-021-08138-3","volume":"21","author":"H Feng","year":"2021","unstructured":"Feng H, Li B, Li Z, Wei Q, Ren L. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer. 2021;21(1):401.","journal-title":"BMC Cancer"},{"issue":"4","key":"1588_CR18","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s12072-024-10668-4","volume":"18","author":"H Gao","year":"2024","unstructured":"Gao H, Xie C, Wang J, Ma J, Liu S, Xie L, Zheng Y, Dong R, Wang S, Fang Y, et al. PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study. Hepatol Int. 2024;18(4):1326\u201335.","journal-title":"Hepatol Int"},{"issue":"10","key":"1588_CR19","first-page":"1155","volume":"136","author":"Z Wang","year":"2023","unstructured":"Wang Z, Qin H, Liu S, Sheng J, Zhang X. Precision diagnosis of hepatocellular carcinoma. Chin Med J (Engl). 2023;136(10):1155\u201365.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"1588_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2214\/AJR.21.26982","volume":"219","author":"LM Loy","year":"2022","unstructured":"Loy LM, Low HM, Choi JY, Rhee H, Wong CF, Tan CH. Variant Hepatocellular Carcinoma subtypes according to the 2019 WHO classification: an imaging-focused review. AJR Am J Roentgenol. 2022;219(2):212\u201323.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"1588_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1159\/000509424","volume":"9","author":"J Zhou","year":"2020","unstructured":"Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, Zhou W, Bie P, Liu L, Wen T, et al. Guidelines for the diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer. 2020;9(6):682\u2013720.","journal-title":"Liver Cancer"},{"issue":"1","key":"1588_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12876-023-02804-5","volume":"23","author":"H Luo","year":"2023","unstructured":"Luo H, Huang C, Meng M, Zhang M, Li Z, Huang J. Combination of neutrophil\/lymphocyte ratio and albumin\/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy. BMC Gastroenterol. 2023;23(1):162.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"1588_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1272\/jnms.JNMS.2022_89-224","volume":"89","author":"Y Kawano","year":"2022","unstructured":"Kawano Y, Kaneya Y, Aoki Y, Yoshioka M, Matsushita A, Shimizu T, Ueda J, Takata H, Taniai N, Kanda T, et al. Medical Treatment for Hepatocellular Carcinoma in Japan. J Nippon Med Sch. 2022;89(2):154\u201360.","journal-title":"J Nippon Med Sch"},{"key":"1588_CR24","doi-asserted-by":"crossref","unstructured":"Castaldo A, De Lucia DR, Pontillo G, Gatti M, Cocozza S, Ugga L, Cuocolo R. State of the art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma. Diagnostics (Basel) 2021, 11(7).","DOI":"10.3390\/diagnostics11071194"},{"key":"1588_CR25","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.2147\/JHC.S434895","volume":"10","author":"HF Liu","year":"2023","unstructured":"Liu HF, Lu Y, Wang Q, Lu YJ, Xing W. Machine learning-based CEMRI radiomics integrating LI-RADS features achieves optimal evaluation of Hepatocellular Carcinoma differentiation. J Hepatocell Carcinoma. 2023;10:2103\u201315.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"1588_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00261-022-03679-y","volume":"48","author":"YE Han","year":"2023","unstructured":"Han YE, Cho Y, Kim MJ, Park BJ, Sung DJ, Han NY, Sim KC, Park YS, Park BN. Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study. Abdom Radiol (NY). 2023;48(1):244\u201356.","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"1588_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cgh.2022.01.047","volume":"21","author":"N Tayob","year":"2023","unstructured":"Tayob N, Kanwal F, Alsarraj A, Hernaez R, El-Serag HB. The performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): a phase 3 Biomarker Study in the United States. Clin Gastroenterol Hepatol. 2023;21(2):415\u2013e423414.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1588_CR28","doi-asserted-by":"crossref","unstructured":"Zhou Z, Liu J, Xu X. A commentary on \u2018Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: a retrospective cohort study\u2019 (Int J Surg 2022;105:106843). Int J Surg 2023, 109(11):3656\u20133658.","DOI":"10.1097\/JS9.0000000000000119"},{"key":"1588_CR29","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2147\/JHC.S417878","volume":"10","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Cao S, Chen C, Chen J, Xu X, Liu Y, Liu Q, Wang K, Han B, Yin Y. A Novel Nomogram for the preoperative prediction of Edmondson-Steiner Grade III-IV in Hepatocellular Carcinoma patients. J Hepatocell Carcinoma. 2023;10:1399\u2013409.","journal-title":"J Hepatocell Carcinoma"},{"issue":"5","key":"1588_CR30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"8","key":"1588_CR31","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1007\/s13277-015-3281-x","volume":"36","author":"TC Xue","year":"2015","unstructured":"Xue TC, Jia QA, Ge NL, Zhang BH, Wang YH, Ren ZG, Ye SL. The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization. Tumour Biol. 2015;36(8):6045\u201351.","journal-title":"Tumour Biol"},{"issue":"10","key":"1588_CR32","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1016\/j.acra.2024.02.035","volume":"31","author":"F Wang","year":"2024","unstructured":"Wang F, Qin Y, Wang ZM, Yan CY, He Y, Liu D, Wen L, Zhang D. A dynamic online Nomogram based on Gd-EOB-DTPA-Enhanced MRI and inflammatory biomarkers for preoperative prediction of pathological Grade and Stratification in Solitary Hepatocellular Carcinoma: a Multicenter Study. Acad Radiol. 2024;31(10):4021\u201333.","journal-title":"Acad Radiol"},{"key":"1588_CR33","doi-asserted-by":"crossref","unstructured":"Li J, Wang Q-B, Liang Y-B, Chen X-M, Luo W-L, Li Y-K, Chen X, Lu Q-Y, Ke Y. Tumor-associated lymphatic vessel density is a reliable biomarker for prognosis of esophageal cancer after radical resection: a systemic review and meta-analysis. Front Immunol 2024, 15.","DOI":"10.3389\/fimmu.2024.1453482"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01588-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01588-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01588-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T21:14:02Z","timestamp":1739826842000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01588-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1588"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01588-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5382448\/v1","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods used in this study were conducted in accordance with the Declaration of Helsinki and approved by the local institutional review board (Ethics Committee of the Second Hospital of Jilin University). Informed consent was waived for this retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}